6-(4-Chlorobenzyl)-9-(oxetan-3-yl)-8,9,10,11-tetrahydropyrido-[4',3':4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one

ID: ALA4084358

PubChem CID: 118485601

Max Phase: Preclinical

Molecular Formula: C20H18ClN5O2S

Molecular Weight: 427.92

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1n(Cc2ccc(Cl)cc2)c2sc3c(c2c2ncnn12)CCN(C1COC1)C3

Standard InChI:  InChI=1S/C20H18ClN5O2S/c21-13-3-1-12(2-4-13)7-25-19-17(18-22-11-23-26(18)20(25)27)15-5-6-24(8-16(15)29-19)14-9-28-10-14/h1-4,11,14H,5-10H2

Standard InChI Key:  YNHRARXBLWKRFA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 34  0  0  0  0  0  0  0  0999 V2000
   13.1814  -17.9429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8946  -18.3412    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9070  -19.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2062  -19.5770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4931  -19.1787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4807  -18.3616    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6707  -18.0791    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.1600  -18.7326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6851  -19.4013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.0434  -20.3787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2349  -20.4751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8937  -19.7305    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.9115  -21.2249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5369  -21.0322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2135  -21.7820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4008  -21.8825    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1731  -17.1258    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.6219  -23.6923    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.3797  -23.3901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0774  -22.6322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3196  -22.9345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7676  -17.9591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7552  -17.1420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4600  -16.7274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4476  -15.9104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7345  -15.5079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0337  -15.9266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0420  -16.7437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7221  -14.6908    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  1  0
  7  8  2  0
  8  9  1  0
  2  7  1  0
  3  9  2  0
 10 11  2  0
 11 12  1  0
 14 15  1  0
 15 16  1  0
 13 16  1  0
 10 14  1  0
 11 13  1  0
  4 10  1  0
  5 12  1  0
  1 17  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 18 21  1  0
 16 20  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 23 28  2  0
 26 29  1  0
  6 22  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

PDE1B Tclin Phosphodiesterase 1B (178 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE10A Tclin Phosphodiesterase 10A (5542 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver (4264 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 427.92Molecular Weight (Monoisotopic): 427.0870AlogP: 2.56#Rotatable Bonds: 3
Polar Surface Area: 64.66Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.63CX LogP: 3.33CX LogD: 3.33
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -1.54

References

1. Dyck B, Branstetter B, Gharbaoui T, Hudson AR, Breitenbucher JG, Gomez L, Botrous I, Marrone T, Barido R, Allerston CK, Cedervall EP, Xu R, Sridhar V, Barker R, Aertgeerts K, Schmelzer K, Neul D, Lee D, Massari ME, Andersen CB, Sebring K, Zhou X, Petroski R, Limberis J, Augustin M, Chun LE, Edwards TE, Peters M, Tabatabaei A..  (2017)  Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties.,  60  (8): [PMID:28406621] [10.1021/acs.jmedchem.7b00302]

Source